XML 45 R31.htm IDEA: XBRL DOCUMENT v3.22.0.1
Leases (Notes)
 12 Months Ended
Jan. 02, 2022
Disclosure Text Block [Abstract]  
Leases [Text Block] Leases
Lessee Disclosures
The Company leases certain property and equipment under operating and finance leases. The Company's leases have remaining lease terms of less than 1 year to 30 years, some of which include options to extend the lease for up to 5 years, and some of which include options to terminate the lease within 1 year. Finance leases are not material to the Company.
The components of lease expense were as follows:
 January 2,
2022		January 3,
2021		December 29,
2019
 (In thousands)
Lease Cost:
Operating lease cost$54,639 $56,977 61,205 
Supplemental cash flow information related to leases was as follows:
 January 2,
2022		January 3,
2021		December 29,
2019
 (In thousands)
Cash paid for amounts included in the measurement of lease liabilities:
Operating cash flows from operating leases$53,455 $47,427 $50,155 
Right-of-use assets obtained in exchange for new lease obligations:
   Operating leases$18,694 $5,048 $5,685 
Supplemental balance sheet information related to leases was as follows:
 January 2,
2022		January 3,
2021
 (In thousands, except lease term and discount rate)
Operating Leases:
Operating lease right-of-use assets$207,775 $207,236 
Operating lease liabilities included in Accrued expenses and other current liabilities$40,567 $40,330 
Operating lease liabilities185,359 188,402 
Total operating lease liabilities$225,926 $228,732 
Weighted Average Remaining Lease Term in Years
Operating leases7.68.1
Weighted Average Remaining Discount Rate
Operating leases2.6%2.9%

Lease costs from finance leases, short-term leases, variable lease costs and sub-lease income are not material.
Future payments of operating lease liabilities as of January 2, 2022 were as follows:
 (In thousands)
2022$47,910 
202338,072 
202431,624 
202527,899 
202624,279 
2027 and thereafter73,967 
Total lease payments243,751 
Less imputed interest(17,825)
    Total $225,926 
Lessor Disclosures
Certain of the Company's contracts require that it place its instrument at the customer's site and sell reagents to the customer. As the predominant component in these contracts are the sales of reagents, the Company accounts for the combined component under ASC 606 only when both of the following criteria are met: 1) the timing and pattern of transfer of the non-lease component or components and associated lease component are the same; and 2) the lease component, if accounted for separately, would be classified as an operating lease. When only one of the criteria is met, the Company accounts for the non-lease component under ASC 606 and the lease component under ASC 842. Profit or loss, interest income and aggregate net investment in sales-type leases that did not qualify for the practical expedient are not material to the Company.